Alphatec Holdings, Inc. · NASDAQ (us_market)
Healthcare · Medical Devices · United States
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. The company manufactures and sells implants, instruments, imaging equipment, and spare parts. It offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; SafeOp Neural InformatiX System that automates electromyographic, somatosensory evoked potential, and motor evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissue; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. The company was founded in 1990 and is headquartered in Carlsbad, California.
| Event Period | Drawdown | Buy Point (Bottom) | Sell Point (Peak) | ticker.setupCols.buyScore | ticker.setupCols.sellScore | Max Return | Algo Return |
|---|---|---|---|---|---|---|---|
DROP2026-01-08$22.68 RISE2026-05-11$6.99 PEAK2026-05-22$8.27 134d | -69.2% 123d | Missed | Missed | — | — | +18.3% 11d | Missed |
DROP2026-01-08$22.68 RISE2026-05-06$6.99 PEAK2026-05-22$8.27 134d | -69.2% 118d | Missed | Missed | — | — | +18.3% 16d | Missed |
DROP2025-09-04$16.55 RISE2025-10-10$13.14 PEAK2025-11-26$22.59 83d | -20.6% 36d | Missed | Missed | — | — | +71.9% 47d | Missed |
DROP2025-05-19$13.03 RISE2025-07-21$10.31 PEAK2025-09-04$16.55 108d | -20.9% 63d | Missed | Missed | — | — | +60.5% 45d | Missed |
DROP2025-02-28$12.53 RISE2025-03-13$9.27 PEAK2025-05-19$13.03 80d | -26.0% 13d | Missed | Missed | — | — | +40.6% 67d | Missed |
DROP2024-11-29$10.48 RISE2024-12-18$8.82 PEAK2025-02-28$12.53 91d | -15.8% 19d | Missed | Missed | — | — | +42.1% 72d | Missed |
DROP2024-07-16$11.87 RISE2024-10-10$4.98 PEAK2024-11-29$10.48 136d | -58.0% 86d | Missed | Missed | — | — | +110.4% 50d | Missed |
DROP2024-02-09$16.78 RISE2024-06-04$9.49 PEAK2024-07-16$11.87 158d | -43.4% 116d | Missed | Missed | — | — | +25.1% 42d | Missed |
DROP2023-07-13$18.80 RISE2023-10-30$8.89 PEAK2024-01-26$16.25 197d | -52.7% 109d | Missed | Missed | — | — | +82.8% 88d | Missed |
DROP2022-10-26$10.50 RISE2022-11-09$8.91 PEAK2023-01-18$13.49 84d | -15.1% 14d | Missed | Missed | — | — | +51.4% 70d | Missed |
DROP2022-04-28$11.40 RISE2022-09-06$7.24 PEAK2022-10-26$10.50 181d | -36.5% 131d | Missed | Missed | — | — | +45.0% 50d | Missed |
DROP2022-04-20$13.08 RISE2022-06-21$6.36 PEAK2022-08-15$9.74 117d | -51.4% 62d | Missed | Missed | — | — | +53.1% 55d | Missed |
DROP2021-09-22$14.36 RISE2022-01-27$9.45 PEAK2022-04-20$13.08 210d | -34.2% 127d | Missed | Missed | — | — | +38.4% 83d | Missed |
DROP2021-08-04$15.23 RISE2021-11-26$10.57 PEAK2022-01-11$12.85 160d | -30.6% 114d | Missed | Missed | — | — | +21.6% 46d | Missed |
DROP2021-04-15$17.23 RISE2021-08-19$11.83 PEAK2021-09-03$15.11 141d | -31.3% 126d | Missed | Missed | — | — | +27.7% 15d | Missed |
1–15 / 19 1 / 2 | |||||||
With a five-year EPS forecast of 158.80%, Alphatec Holdings, Inc. (NASDAQ:ATEC) is among the 12 Best Future Stocks to Buy Right Now. On May 7, Barclays analyst Matt Miksic lowered the firm’s price target on Alphatec Holdings, Inc. (NASDAQ:ATEC) to $24 from $27 while maintaining an Overweight rating on the shares. Despite the lower target, Barclays kept […]
Over the last 7 days, the United States market has experienced a 1.0% drop, yet it remains up by 23% over the past year with earnings projected to grow by 17% annually. In this context, identifying growth companies with strong insider ownership can be an effective strategy as these firms often demonstrate commitment and confidence from those who know them best.
Alphatec stock is down 2/3 YTD: slowing growth, debt and dilution vs improving EBITDA leverage.
More than 1,500 stocks have reported earnings since the current season began, and the average stock that's reported has seen an average absolute one-day share price reaction of roughly 7%.
Polen Capital, an investment management company, released its first-quarter 2025 investor letter for “Polen 5Perspectives Small Growth Strategy”. A copy of the letter is available to download here. Polen 5Perspectives Small Growth Composite Portfolio returned 3.3% gross and 3.0% net of fees, respectively, in the first quarter of 2026, compared to the -2.8% return of the […]
Alphatec Holdings, Inc. (ATEC) Bank of America Global Healthcare Conference 2026 May 12, 2026 8:15 PM EDTCompany ParticipantsJ.
Presenter SpeechUnknown Analyst Bank of America, really happy to introduce ATEC Spine. For our next presentation, we have CFO, Todd Koning.Presenter SpeechJ. Koning Thanks, Adrian. Appreciate you
Alphatec Holdings, Inc. (NASDAQ:ATEC) is one of the best healthcare stocks to buy for the long term. Alphatec Holdings, Inc. (NASDAQ:ATEC) received several rating updates following the release of its fiscal Q1 2026 results on May 5, with surgical revenue growing 17% and total revenue growing 14%. Canaccord cut the price target on the stock […]
There's been a major selloff in Alphatec Holdings, Inc. ( NASDAQ:ATEC ) shares in the week since it released its...
This medical technology company delivers advanced spinal surgery devices and biologics to U.S. hospitals and healthcare providers.
Barclays analyst Matt Miksic maintains Alphatec Holdings (NASDAQ:ATEC) with a Overweight and lowers the price target from $27 to $24.
Wells Fargo analyst Larry Biegelsen maintains Alphatec Holdings (NASDAQ:ATEC) with a Overweight and lowers the price target from $28 to $14.
HC Wainwright & Co. analyst Sean Lee reiterates Alphatec Holdings (NASDAQ:ATEC) with a Buy and maintains $24 price target.
Canaccord Genuity analyst Caitlin Cronin maintains Alphatec Holdings (NASDAQ:ATEC) with a Buy and lowers the price target from $25 to $23.
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
JP Morgan analyst Allen Gong maintains Alphatec Holdings (NASDAQ:ATEC) with a Overweight and lowers the price target from $24 to $16.
Keep an eye on the top gainers and losers in Wednesday's session, as they reflect the most notable price movements.
TD Cowen analyst Mathew Blackman maintains Alphatec Holdings (NASDAQ:ATEC) with a Buy and lowers the price target from $20 to $11.
The market is buzzing with gapping stocks on Wednesday. Let's uncover which stocks are experiencing notable gaps during today's session.
Leading contributors in the Fund included Ultra Clean Holdings, Oil States International, Lincoln Educational Services, Advanced Energy and FormFactor.
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| ATEC | -25.70% | -42.46% | -63.17% | -37.65% |
| XLV | +2.97% | -5.72% | -3.44% | +12.69% |
| Alpha (stock − sector) | -28.66% | -36.75% | -59.72% | -50.34% |
| Fund | Style | Shares | Value | % of Port | Change vs. last quarter | Period |
|---|---|---|---|---|---|---|
| StateStreet | passive | 3.03M | $32.98M | 0.00% | Added+4.9% | 2026-03-31 |
| Citadel | multi-strat | 2.49M | $27.13M | 0.03% | Added+126.7% | 2026-03-31 |
| TwoSigma | quant | 2.04M | $22.23M | 0.02% | Added+3.8% | 2026-03-31 |
| RenTech | quant | 1.06M | $11.48M | 0.02% | Added+21.3% | 2026-03-31 |
| FidelityFMR | fundamental | 287.4K | $3.13M | 0.00% | Trimmed-40.2% | 2026-03-31 |
| DEShaw | quant | 18.5K | $201.52K | 0.00% | Trimmed-93.1% | 2026-03-31 |
| TRowePrice | fundamental | 119.5K | $1.30K | 0.00% | Added+27.6% | 2026-03-31 |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-07-30upcoming | 0.07 | — | — |
| 2026-05-05 | — | — | +100.00% |
| 2026-02-24 | 0.04 | 0.06 | +44.93% |
| 2025-10-30 | -0.02 | 0.03 | +233.39% |
| 2025-07-31 | -0.04 | 0.02 | +148.00% |
| 2025-05-01 | -0.12 | -0.09 | +27.18% |
| 2025-02-26 | -0.07 | -0.06 | +13.11% |
| 2024-10-30 | -0.11 | -0.13 | -23.49% |
| 2024-07-31 | -0.12 | -0.14 | -18.09% |
| 2024-05-07 | -0.14 | -0.16 | -7.91% |
| 2024-02-27 | -0.07 | -0.11 | -46.17% |
| 2023-11-06 | -0.08 | -0.11 | -24.82% |
| 2023-08-03 | -0.12 | -0.12 | +1.86% |
| 2023-05-04 | -0.16 | -0.18 | -14.25% |
| 2023-02-28 | -0.15 | -0.14 | +8.51% |
| 2022-11-03 | -0.17 | -0.15 | +9.94% |